FDA Inspection 1297650 — Halo Pharmaceutical, Inc. D/B/A Cambrex Whippany
The FDA completed an inspection of Halo Pharmaceutical, Inc. D/B/A Cambrex Whippany on Dec 8, 2025 in Whippany, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Veterinary.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 8, 2025
- Fiscal Year
- 2026
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Whippany, NJ (United States)